ATE124457T1 - Hemmung der viralen replikation. - Google Patents

Hemmung der viralen replikation.

Info

Publication number: ATE124457T1
Authority: AT; Austria
Prior art keywords: inhibition; viral replication; dna; cell; viral
Prior art date: 1990-10-09

Application number

AT91919581T

Other languages

English (en)

Inventor

Michael J Scolaro

Sean M Sullivan

Original Assignee

Vestar Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-09

Filing date

1991-10-09

Publication date

1995-07-15

1991-10-09 Application filed by Vestar Inc filed Critical Vestar Inc

1995-07-15 Application granted granted Critical

1995-07-15 Publication of ATE124457T1 publication Critical patent/ATE124457T1/de

Links

230000005764 inhibitory process Effects 0.000 title 1
230000029812 viral genome replication Effects 0.000 title 1
108020004414 DNA Proteins 0.000 abstract 2
108091033380 Coding strand Proteins 0.000 abstract 1
108091034117 Oligonucleotide Proteins 0.000 abstract 1
108010052104 Viral Regulatory and Accessory Proteins Proteins 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
230000003834 intracellular effect Effects 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
AIDS & HIV (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Communicable Diseases (AREA)
Plant Pathology (AREA)
Dispersion Chemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT91919581T 1990-10-09 1991-10-09 Hemmung der viralen replikation. ATE124457T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US59525390A	1990-10-09	1990-10-09

Publications (1)

Publication Number	Publication Date
ATE124457T1 true ATE124457T1 (de)	1995-07-15

Family

ID=24382446

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91919581T ATE124457T1 (de)	1990-10-09	1991-10-09	Hemmung der viralen replikation.

Country Status (9)

Country	Link
EP (1)	EP0552280B1 (de)
JP (1)	JPH06504429A (de)
AT (1)	ATE124457T1 (de)
AU (1)	AU652006B2 (de)
CA (1)	CA2093816A1 (de)
DE (1)	DE69110897T2 (de)
DK (1)	DK0552280T3 (de)
ES (1)	ES2073777T3 (de)
WO (1)	WO1992006192A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3351476B2 (ja) *	1993-01-22	2002-11-25	三菱化学株式会社	リン脂質誘導体及びそれを含有するリポソーム
WO1995016437A1 (en) *	1993-12-17	1995-06-22	Micro-Pak, Inc.	Method of transmitting a biologically active material to a cell
US7135584B2 (en)	1995-08-07	2006-11-14	Wake Forest University	Lipid analogs for treating viral infections
EP0781138B1 (de)	1994-08-29	2008-05-21	Wake Forest University	Lipid-analoge zur behandlung von viralen infektionen
US6776986B1 (en)	1996-06-06	2004-08-17	Novartis Ag	Inhibition of HIV-1 replication by antisense RNA expression
US7026469B2 (en)	2000-10-19	2006-04-11	Wake Forest University School Of Medicine	Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en)	2000-10-19	2007-12-18	Wake Forest University	Compositions and methods for targeting cancer cells
WO2003021959A1 (en)	2001-08-31	2003-03-13	Thomson Licensing Sa	Sequence counter for an audio visual stream
DE602004030923D1 (de)	2003-09-17	2011-02-17	Rodos Biotarget Gmbh	Lipid-arzneimittel-formulierungen zur gezielten pharmakotherapie von myeloiden und lymphoiden immunzellen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0319570B1 (de) *	1987-06-26	1995-02-22	Syntro Corporation	Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung
DE3744785A1 (de) *	1987-12-11	1989-08-17	Theurer Karl Eugen	Verwendung von ruecklaeufigen spiegelbildlichen anti-sense-nucleinsaeuren gegen krebserkrankungen
EP0402402B1 (de) *	1988-02-26	1995-12-27	Worcester Foundation For Biomedical Research, Inc.	Hemmung von htlv-iii durch exogene oligonukleotide

1991
- 1991-10-09 AU AU88759/91A patent/AU652006B2/en not_active Ceased
- 1991-10-09 DK DK91919581.8T patent/DK0552280T3/da active
- 1991-10-09 AT AT91919581T patent/ATE124457T1/de not_active IP Right Cessation
- 1991-10-09 DE DE69110897T patent/DE69110897T2/de not_active Expired - Fee Related
- 1991-10-09 ES ES91919581T patent/ES2073777T3/es not_active Expired - Lifetime
- 1991-10-09 CA CA002093816A patent/CA2093816A1/en not_active Abandoned
- 1991-10-09 EP EP91919581A patent/EP0552280B1/de not_active Expired - Lifetime
- 1991-10-09 WO PCT/US1991/007550 patent/WO1992006192A1/en not_active Ceased
- 1991-10-09 JP JP3518313A patent/JPH06504429A/ja active Pending

Also Published As

Publication number	Publication date
AU652006B2 (en)	1994-08-11
EP0552280A1 (de)	1993-07-28
DE69110897D1 (de)	1995-08-03
EP0552280B1 (de)	1995-06-28
DE69110897T2 (de)	1995-11-30
WO1992006192A1 (en)	1992-04-16
ES2073777T3 (es)	1995-08-16
AU8875991A (en)	1992-04-28
DK0552280T3 (da)	1995-08-28
CA2093816A1 (en)	1992-04-10
JPH06504429A (ja)	1994-05-26

Similar Documents

Publication	Publication Date	Title
DE69819167D1 (de)	2003-11-27	Modifizierter, das dorsalgewebe beeinflussender faktor
DE69535125D1 (de)	2006-09-07	Impstoff gegen felines immunodefizienz-virus
DE69730218D1 (de)	2004-09-16	Fusogene liposomen
SE9704546D0 (sv)	1997-12-05	Novel compounds
ATE420190T1 (de)	2009-01-15	Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
NO944245L (no)	1995-01-06	Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
DK0958353T3 (da)	2009-06-29	Phytase polypeptider
DE69110897D1 (de)	1995-08-03	Hemmung der viralen replikation.
MX9101042A (es)	1992-08-10	Adn y arn recombinantes y productos derivados de los mismos
DK0599868T3 (da)	2000-06-26	Polyphenoloxidase-gener
AU2001279581A1 (en)	2002-03-22	Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter
DE69534945D1 (de)	2006-05-24	Impfstoff für die infektiöse peritonitis der katzen
FI902803A7 (fi)	1990-12-06	DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
FI891049A0 (fi)	1989-03-06	En eller flera lockfoersedda oeppningar i arbetspaln, i synnerhet diskbaenk i koek.
DE60042922D1 (de)	2009-10-22	Virale expressionsvektoren für pflanzen
ES2367245T8 (es)	2011-12-09	Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
DE69733948D1 (de)	2005-09-15	In vivo herstellung von replicativen molekülen
WO1998042847A3 (de)	1999-03-11	Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
IT1286307B1 (it)	1998-07-08	Virus mixomatoso ricombinante, suo impiego per la produzione di un vaccino e relativo vaccino.
WO2002083896A3 (en)	2003-03-13	Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
WO2004027066A3 (fr)	2004-05-21	Protéine recombinante chimérique et diagnostic in vitro du hiv
FI964784A0 (fi)	1996-11-29	Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa
AU1557001A (en)	2001-06-12	Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein andgene remedies containing the same for treating diseases associated with glycopr otein abnormality
FI893346A0 (fi)	1989-07-10	Icke-reverterande rna-virus.
FI890231A0 (fi)	1989-01-17	Çkaerlekssigillç, aer ett çlaosç som laoses antingen med verktyg eller foer hand, men som inte kan upplaoses utan att den gaor soender.

Legal Events

Date	Code	Title
1996-01-15	UEP	Publication of translation of european patent specification
1997-09-15	EEIH	Change in the person of patent owner
1999-07-15	REN	Ceased due to non-payment of the annual fee